Editor's note
Neil Love, MD

FEATURING:

Mark S Soloway, MD

Case #1: A 60-year-old with Gleason 6 prostate cancer treated with long-term testosterone replacement after testicular cancer
Case #2: An apparently healthy 48-year-old man with HIV and a Gleason 6, T1c prostate cancer
Case #3: A man with Gleason 7 prostate cancer and a rising PSA one and one-half years after treatment with androgen deprivation and external beam radiation therapy
Trials comparing early versus late hormone therapy for advanced prostate cancer
Early Prostate Cancer Trials: Adjuvant therapy with bicalutamide 150 mg
Patient preference in the timing of androgen deprivation therapy
Watchful waiting as an option for localized prostate cancer

Select publications

Real-time ultrasound-guided 3-D brachytherapy
Combined-modality trial for men with high-risk prostate cancer
Decision-making in patients with low-risk prostate cancer
Brachytherapy versus radial prostatectomy for young men with prostate cancer
“PSA bounce” after brachytherapy

Select publications

Defining PSA failure after radical prostatectomy
Duration of androgen deprivation
Adverse pathologic findings to determine use of adjuvant therapy
Tolerability of endocrine therapy
High-dose anti-androgen monotherapy
Continuous versus intermittent androgen deprivation
ProstaScint® scans in patients with biochemical relapse

Select publications